Raymond James Reiterates Strong Buy Rating on Vera Therapeutics (VERA)

September 15, 2026 9:58 AM

Raymond James analyst Ryan Deschner reiterated a Strong Buy rating and $84.00 price target on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found